|
2024 Journal Article Peritumoral administration of immunomodulatory antibodies as a triple combination suppresses skin tumor growth without systemic toxicityWright, Quentin G., Sinha, Debottam, Wells, James W., Frazer, Ian H., Gonzalez Cruz, Jazmina L. and Leggatt, Graham Robert (2024). Peritumoral administration of immunomodulatory antibodies as a triple combination suppresses skin tumor growth without systemic toxicity. Journal for ImmunoTherapy of Cancer, 12 (1) e007960. doi: 10.1136/jitc-2023-007960 |
|
2021 Journal Article 'Off-the-shelf' allogeneic antigen-specific adoptive T-cell therapy for the treatment of multiple EBV-associated malignanciesSinha, Debottam, Srihari, Sriganesh, Beckett, Kirrliee, Le Texier, Laetitia, Solomon, Matthew, Panikkar, Archana, Ambalathingal, George R., Lekieffre, Lea, Crooks, Pauline, Rehan, Sweera, Neller, Michelle A., Smith, Corey and Khanna, Rajiv (2021). 'Off-the-shelf' allogeneic antigen-specific adoptive T-cell therapy for the treatment of multiple EBV-associated malignancies. Journal for Immunotherapy of Cancer, 9 (2) e001608, e001608. doi: 10.1136/jitc-2020-001608 |
|
2020 Journal Article Cep55 overexpression promotes genomic instability and tumorigenesis in miceSinha, Debottam, Nag, Purba, Nanayakkara, Devathri, Duijf, Pascal H. G., Burgess, Andrew, Raninga, Prahlad, Smits, Veronique A. J., Bain, Amanda L., Subramanian, Goutham, Wall, Meaghan, Finnie, John. W., Kalimutho, Murugan and Khanna, Kum Kum (2020). Cep55 overexpression promotes genomic instability and tumorigenesis in mice. Communications Biology, 3 (1) 593, 1-16. doi: 10.1038/s42003-020-01304-6 |
|
Featured 2020 Journal Article Joining Forces: Improving Clinical Response to Cellular Immunotherapies with Small-Molecule InhibitorsSinha, Debottam, Smith, Corey and Khanna, Rajiv (2020). Joining Forces: Improving Clinical Response to Cellular Immunotherapies with Small-Molecule Inhibitors. Trends in Molecular Medicine, 27 (1), 75-90. doi: 10.1016/j.molmed.2020.09.005 |
|
2019 Journal Article Blockade of PDGFRβ circumvents resistance to MEK-JAK inhibition via intratumoral CD8+ T-cells infiltration in triple-negative breast cancerKalimutho, Murugan, Sinha, Debottam, Mittal, Deepak, Srihari, Sriganesh, Nanayakkara, Devathri, Shafique, Shagufta, Raninga, Prahlad, Nag, Purba, Parsons, Kate and Khanna, Kum Kum (2019). Blockade of PDGFRβ circumvents resistance to MEK-JAK inhibition via intratumoral CD8+ T-cells infiltration in triple-negative breast cancer. Journal of Experimental and Clinical Cancer Research, 38 (1) 85, 1-18. doi: 10.1186/s13046-019-1075-5 |
|
2019 Journal Article Mitotic slippage: an old tale with a new twistSinha, Debottam, Duijf, Pascal H.G. and Khanna, Kum Kum (2019). Mitotic slippage: an old tale with a new twist. Cell Cycle, 18 (1), 7-15. doi: 10.1080/15384101.2018.1559557 |
|
2018 Journal Article CEP55 is a determinant of cell fate during perturbed mitosis in breast cancerKalimutho, Murugan, Sinha, Debottam, Jeffery, Jessie, Nones, Katia, Srihari, Sriganesh, Fernando, Winnie C., Duijf, Pascal H. G., Vennin, Claire, Raninga, Prahlad, Nanayakkara, Devathri, Mittal, Deepak, Saunus, Jodi M., Lakhani, Sunil R., López, J Alejandro, Spring, Kevin J., Timpson, Paul, Gabrielli, Brian, Waddell, Nicola and Khanna, Kum Kum (2018). CEP55 is a determinant of cell fate during perturbed mitosis in breast cancer. EMBO Molecular Medicine, 10 (9) e8566. doi: 10.15252/emmm.201708566 |
|
2018 Journal Article Cep55 overexpression causes male-specific sterility in mice by suppressing Foxo1 nuclear retention through sustained activation of PI3K/Akt signalingSinha, Debottam, Kalimutho, Murugan, Bowles, Josephine, Chan, Ai-Leen, Merriner, D. Jo, Bain, Amanda L., Simmons, Jacinta L., Freire, Raimundo, Lopez, J Alejandro, Hobbs, Robin M., O'Bryan, Moira K. and Khanna, Kum Kum (2018). Cep55 overexpression causes male-specific sterility in mice by suppressing Foxo1 nuclear retention through sustained activation of PI3K/Akt signaling. The FASEB Journal, 32 (9), 4984-4999. doi: 10.1096/fj.201701096RR |
|
Featured 2016 Journal Article Adenosine 2B receptor expression on cancer cells promotes metastasisMittal, Deepak, Sinha, Debottam, Barkauskas, Deborah, Young, Arabella, Kalimutho, Murugan, Stannard, Kimberley, Caramia, Franco, Haibe-Kains, Benjamin, Stagg, John, Khanna, Kum Kum, Loi, Sherene and Smyth, Mark J. (2016). Adenosine 2B receptor expression on cancer cells promotes metastasis. Cancer Research, 76 (15), 4372-4382. doi: 10.1158/0008-5472.CAN-16-0544 |
|
2015 Journal Article Beyond cytokinesis: the emerging roles of CEP55 in tumorigenesisJeffery, J., Sinha, D., Srihari, S., Kalimutho, M. and Khanna, K. K. (2015). Beyond cytokinesis: the emerging roles of CEP55 in tumorigenesis. Oncogene, 35 (6), 683-690. doi: 10.1038/onc.2015.128 |
|
2024 Journal Article Characterization of the skin microbiome in normal and cutaneous squamous cell carcinoma affected cats and dogsBromfield, Jacoba I., Zaugg, Julian, Straw, Rodney C., Cathie, Julia, Krueger, Annika, Sinha, Debottam, Chandra, Janin, Hugenholtz, Philip and Frazer, Ian H. (2024). Characterization of the skin microbiome in normal and cutaneous squamous cell carcinoma affected cats and dogs. mSphere, 9 (4) e0055523, e0055523. doi: 10.1128/msphere.00555-23 |
|
2023 Journal Article Molecular mechanisms augmenting resistance to current therapies in clinics among cervical cancer patientsDas, Soumik, Babu, Achsha, Medha, Tamma, Ramanathan, Gnanasambandan, Mukherjee, Anirban Goutam, Wanjari, Uddesh Ramesh, Murali, Reshma, Kannampuzha, Sandra, Gopalakrishnan, Abilash Valsala, Renu, Kaviyarasi, Sinha, Debottam and George Priya Doss, C. (2023). Molecular mechanisms augmenting resistance to current therapies in clinics among cervical cancer patients. Medical Oncology, 40 (5) 149, 149. doi: 10.1007/s12032-023-01997-9 |
|
2022 Journal Article Repurposing of commercially existing molecular target therapies to boost the clinical efficacy of immune checkpoint blockadeSinha, Debottam, Moseley, Philip, Lu, Xuehan, Wright, Quentin, Gabrielli, Brian, Frazer, Ian H. and Cruz, Jazmina L. G. (2022). Repurposing of commercially existing molecular target therapies to boost the clinical efficacy of immune checkpoint blockade. Cancers, 14 (24) 6150, 1-26. doi: 10.3390/cancers14246150 |
|
2022 Conference Publication Targeting of immune regulatory proteins through locoregional delivery of mAbs augments CD8 T cell mediated anti-tumour responses in vivoWright, Q., Sinha, D., Gonzalez-Cruz, J., Frazer, I. and Leggatt, G. (2022). Targeting of immune regulatory proteins through locoregional delivery of mAbs augments CD8 T cell mediated anti-tumour responses in vivo. ESMO Immuno-Oncology Congress 2022, Geneva, Switzerland, 7-9 December 2022. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.iotech.2022.100289 |
|
2021 Journal Article Cep55 regulation of PI3K/Akt signaling is required for neocortical development and ciliogenesisRashidieh, Behnam, Shohayeb, Belal, Bain, Amanda Louise, Fortuna, Patrick R. J., Sinha, Debottam, Burgess, Andrew, Mills, Richard, Adams, Rachael C., Lopez, J. Alejandro, Blumbergs, Peter, Finnie, John, Kalimutho, Murugan, Piper, Michael, Hudson, James Edward, Ng, Dominic C. H. and Khanna, Kum Kum (2021). Cep55 regulation of PI3K/Akt signaling is required for neocortical development and ciliogenesis. PLoS Genetics, 17 (10) e1009334, 1-31. doi: 10.1371/journal.pgen.1009334 |
|
2021 Conference Publication Preclinical assessment of off-the-shelf allogeneic T-cell therapy for the treatment of multiple Epstein-Barr virus-associated malignanciesSinha, D. and Khanna, R. (2021). Preclinical assessment of off-the-shelf allogeneic T-cell therapy for the treatment of multiple Epstein-Barr virus-associated malignancies. ISCT2021, Virtual, 26-28 May 2021. Oxford, United Kingdom: Elsevier. doi: 10.1016/s1465324921004151 |
|
2021 Journal Article EBV and myeloid-derived suppressor cellsSinha, Debottam and Khanna, Rajiv (2021). EBV and myeloid-derived suppressor cells. Blood, 137 (2), 148-150. doi: 10.1182/blood.2020008640 |
|
2020 Journal Article Pre-transplant cytomegalovirus-specific cellular immunity and risk of viral reactivation following lung transplantation: a prospective cohort studyAltaf, Mohammed, Lineburg, Katie E., Crooks, Pauline, Rehan, Sweera, Matthews, Katherine K., Neller, Michelle A, Ambalathingal, George R., Sinha, Debottam, Grant, Michelle, Hopkins, Peter M. A., Chambers, Daniel, Khanna, Rajiv and Smith, Corey (2020). Pre-transplant cytomegalovirus-specific cellular immunity and risk of viral reactivation following lung transplantation: a prospective cohort study. The Journal of infectious diseases, 224 (2), 312-317. doi: 10.1093/infdis/jiaa750 |
|
2020 Journal Article Therapeutic cooperation between auranofin, a thioredoxin reductase inhibitor and anti-PD-L1 antibody for treatment of triple-negative breast cancerRaninga, Prahlad V., Lee, Andy C., Sinha, Debottam, Shih, Yu-Yin, Mittal, Deepak, Makhale, Ashwini, Bain, Amanda L., Nanayakarra, Devathri, Tonissen, Kathryn F., Kalimutho, Murugan and Khanna, Kum Kum (2020). Therapeutic cooperation between auranofin, a thioredoxin reductase inhibitor and anti-PD-L1 antibody for treatment of triple-negative breast cancer. International Journal of Cancer, 146 (1), 123-136. doi: 10.1002/ijc.32410 |
|
2020 Journal Article Marizomib suppresses triple-negative breast cancer via proteasome and oxidative phosphorylation inhibitionRaninga, Prahlad, Lee, Andy, Sinha, Debottam, Dong, Lan-feng, Datta, Keshava, Lu, Xue, Kalita-de Croft, Priyakshi, Dutt, Mriga, Hill, Michelle M., Pouliot, Normand M., Gowda, Harsha, Kalimutho, Murugan, Neuzil, Jiri and Khanna, Kum Kum (2020). Marizomib suppresses triple-negative breast cancer via proteasome and oxidative phosphorylation inhibition. Theranostics, 10 (12), 5259-5275. doi: 10.7150/thno.42705 |
